Advertisement

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib

Farrukh T. Awan, Anna Schuh, Jennifer R. Brown, Richard R. Furman, John M. Pagel, Peter Hillmen, Deborah M. Stephens, Jennifer Woyach, Elena Bibikova, Prista Charuworn, Melanie M. Frigault, Ahmed Hamdy, Raquel Izumi, Bolan Linghu, Priti Patel, Min Hui Wang and John C. Byrd

Article Information

Citation 
vol. 3 no. 9 1553-1562
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted December 14, 2018
  • Accepted March 8, 2019
  • Published online May 14, 2019.


Contributors 
  • Farrukh T. Awan, 1Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX;
  • Anna Schuh, 2Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;
  • Jennifer R. Brown, 3Dana-Farber Cancer Institute, Boston, MA;
  • Richard R. Furman, 4New York–Presbyterian Hospital, Weill Cornell Medicine, New York, NY;
  • John M. Pagel, 5Swedish Cancer Institute, Seattle, WA;
  • Peter Hillmen, 6St. James’s University Hospital, Leeds, United Kingdom;
  • Deborah M. Stephens, 7Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;
  • Jennifer Woyach, 8The Ohio State University Comprehensive Cancer Center, Columbus, OH;
  • Elena Bibikova, 9Acerta Pharma, South San Francisco, CA;
  • Prista Charuworn, 9Acerta Pharma, South San Francisco, CA;
  • Melanie M. Frigault, 9Acerta Pharma, South San Francisco, CA;10Oncology Translational Science, and
  • Ahmed Hamdy, 9Acerta Pharma, South San Francisco, CA;
  • Raquel Izumi, 9Acerta Pharma, South San Francisco, CA;
  • Bolan Linghu, 11Oncology Biosciences, IMED Biotech Unit, AstraZeneca, Boston, MA
  • Priti Patel, 9Acerta Pharma, South San Francisco, CA;
  • Min Hui Wang, 9Acerta Pharma, South San Francisco, CA;
  • John C. Byrd, 8The Ohio State University Comprehensive Cancer Center, Columbus, OH;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output